MedTrace Logo

Evaluating the Impact of Evidence-based Information About PSA Testing on Prostate Cancer Screening Decisions

NCT03477591 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 308

Last updated 2023-10-19

No results posted yet for this study

Summary

Patient decision aids are tools that help guide individuals through a healthcare-related decision making process. They help users combine evidence-based information and recommendations by a health care provider with their personal needs, values and preferences. Through this project, Dr. Dobbins and her research team will explore whether the use of patient decision aids with high-quality and user-friendly summaries of research evidence, or summaries of research evidence alone, help to improve the quality of decision making by men facing prostate cancer screening decisions.

Conditions

Interventions

OTHER

Evidence-based information

Evidence-based information on PSA testing such as blog posts, plain language evidence summaries and web resource ratings (quality-appraised online resources).

OTHER

Patient Decision Aid

Patient Decision Aid for prostate cancer screening decision

OTHER

Sham information

Educational information not specific to PSA testing or cancer screening

Sponsors & Collaborators

Principal Investigators

  • Maureen Dobbins, RN, PhD · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2019-08-30
Completion
2021-07-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03477591 on ClinicalTrials.gov